Audits of active substance manufacturers and all entities involved in the manufacture of medicinal products constitute a mandatory element of the quality assurance system and a requirement of the marketing authorization documentation. They include both an assessment of GMP compliance and confirmation that processes, documentation, and infrastructure meet applicable regulatory standards.